Cargando…

Influence of ESGC Indicators on Financial Performance of Listed Pharmaceutical Companies

The pharmaceutical industry, concerned about the impact of its activity, has integrated responsible principles and practices with a view to improving its sustainable and financial performance. This study analyzes the relationship between environmental, social, governance, and controversy indicators...

Descripción completa

Detalles Bibliográficos
Autores principales:	López-Toro, Alberto A., Sánchez-Teba, Eva María, Benítez-Márquez, María Dolores, Rodríguez-Fernández, Mercedes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123507/ https://www.ncbi.nlm.nih.gov/pubmed/33923122 http://dx.doi.org/10.3390/ijerph18094556

Ejemplares similares

Regulating pharmaceutical companies’ financial largesse
por: Avraham, Ronen, et al.
Publicado: (2018)

Corporate financialization, financing constraints, and innovation efficiency—Empirical evidence based on listed Chinese pharmaceutical companies
por: Zhu, Jialin, et al.
Publicado: (2023)

Environmental regulation and financial performance of Chinese listed companies
por: Zhou, Bing, et al.
Publicado: (2020)

Financial Crisis Warning for Listed Manufacturing Companies in China
por: Wang, Yang, et al.
Publicado: (2022)

Digital Transformation and Financial Risk Prediction of Listed Companies
por: Xinxian, Chen, et al.
Publicado: (2022)

Financial crisis early warning of Chinese listed companies based on MD&A text-linguistic feature indicators
por: Zhang, Zhishuo, et al.
Publicado: (2023)

An alternative index to the global competitiveness index
por: Benítez-Márquez, María-Dolores, et al.
Publicado: (2022)

Generation Z Young People’s Perception of Sexist Female Stereotypes about the Product Advertising in the Food Industry: Influence on Their Purchase Intention
por: Bermúdez-González, Guillermo, et al.
Publicado: (2021)

Financial Fraud Detection and Prediction in Listed Companies Using SMOTE and Machine Learning Algorithms
por: Zhao, Zhihong, et al.
Publicado: (2022)

Financial Management of Listed Companies Based on Convolutional Neural Network Model in the Context of Epidemic
por: Duan, Qian, et al.
Publicado: (2022)

Air Pollution and Corporate Green Financial Constraints: Evidence from China’s Listed Companies
por: Shen, Yi, et al.
Publicado: (2022)

Pharmacovigilance in pharmaceutical companies: An overview
por: Mammì, Maria, et al.
Publicado: (2013)

Buyouts of Indian Pharmaceutical Companies by Multinational Pharmaceutical Companies: An Issue of Concern
por: Sreedhar, D, et al.
Publicado: (2011)

Generation Z Within the Workforce and in the Workplace: A Bibliometric Analysis
por: Benítez-Márquez, María Dolores, et al.
Publicado: (2022)

Economic and non-economic determinants of Iranian pharmaceutical companies’ financial performance: an empirical study
por: Masoumi, Mohammadreza, et al.
Publicado: (2019)

Assessment of Financial Relationships Between Otorhinolaryngologists and Pharmaceutical Companies in Japan Between 2016 and 2019
por: Kamamoto, Sae, et al.
Publicado: (2023)

The influence of pharmaceutical companies
por: Migone, Paolo
Publicado: (2017)

Supply chain concentration and enterprise financialization: Evidence from listed companies in China’s manufacturing industry
por: He, Huanhuan, et al.
Publicado: (2023)

Impact of the implementation of carbon emission trading on corporate financial performance: Evidence from listed companies in China
por: Liu, Meijuan, et al.
Publicado: (2021)

Coronavirus disease 2019 experts appearing on Japanese television: their characteristics and financial conflicts of interest with pharmaceutical companies
por: Murayama, Anju, et al.
Publicado: (2021)

An attention embedded DUAL-LSTM method for financial risk early warning of the three new board-listed companies
por: Cheng, Xiaojing
Publicado: (2023)

The Valuation of Financial Companies: Tools and Techniques to Measure the Value of Banks, Insurance Companies and Other Financial Institutions
por: Zanetti, Laura
Publicado: (2014)

Pharmacovigilance obligations of the pharmaceutical companies in India
por: Arora, Deepa
Publicado: (2008)

Involvement of pharmaceutical companies at scientific meetings
por: Brink, Andries
Publicado: (2010)

The Pharmaceutical Company Approach to Antibiotic Policies
por: White, Anthony R.
Publicado: (2005)

Ethics, gastroenterologists, and pharmaceutical and equipment companies
por: Roberts‐Thomson, Ian C
Publicado: (2020)

Expected Impact of Biosimilars on the Pharmaceutical Companies
por: Golshani, Shiva, et al.
Publicado: (2021)

The impact of green financial development on stock price crash risk from the perspective of information asymmetry in Chinese listed companies
por: Zhang, Zhibin, et al.
Publicado: (2023)

Medical Affairs in Pharmaceutical Companies and Related Pharmaceutical Regulations in Japan
por: Maeda, Hideki
Publicado: (2021)

Pharmaceutical companies information and antibiotic prescription patterns: A follow-up study in Spanish primary care
por: Fernández-Álvarez, Iria, et al.
Publicado: (2019)

Pharmaceutical Company Targets and Strategies to Address Climate Change: Content Analysis of Public Reports from 20 Pharmaceutical Companies
por: Booth, Amy, et al.
Publicado: (2023)

Digital inclusive finance, financial mismatch and the innovation capacity of small and medium-sized enterprises: Evidence from Chinese listed companies
por: Li, Wenqi, et al.
Publicado: (2023)

Value chain carbon footprints of Chinese listed companies
por: Zhang, Zengkai, et al.
Publicado: (2023)

Error in Payments From Some Pharmaceutical Companies
Publicado: (2019)

Unmet Medical Needs and the Role of Pharmaceutical Companies
por: Meyer-Sabellek, Wolfgang
Publicado: (2009)

Equity incentive contract characteristics and company operational performance—An empirical study of Chinese listed companies
por: Qiao, Mingzhe, et al.
Publicado: (2023)

Gender Diversity on Boards of Directors and Remuneration Committees: The Influence on Listed Companies in Spain
por: García-Izquierdo, Antonio L., et al.
Publicado: (2018)

Undisclosed financial ties between guideline writers and pharmaceutical companies: a cross-sectional study across 10 disease categories
por: Moynihan, Ray, et al.
Publicado: (2019)

Who reports high company performance? A quantitative study of Chinese listed companies in the energy industry
por: Guo, Daoyan, et al.
Publicado: (2016)

Corruption perception, institutional quality and performance of listed companies in Nigeria
por: Ojeka, Stephen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0ag68ldu0angmkivnq2efpj5r0